Neil Blake

2.4k total citations
38 papers, 2.0k citations indexed

About

Neil Blake is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Neil Blake has authored 38 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 17 papers in Immunology and 13 papers in Epidemiology. Recurrent topics in Neil Blake's work include Viral-associated cancers and disorders (15 papers), Immune Cell Function and Interaction (12 papers) and Cytomegalovirus and herpesvirus research (9 papers). Neil Blake is often cited by papers focused on Viral-associated cancers and disorders (15 papers), Immune Cell Function and Interaction (12 papers) and Cytomegalovirus and herpesvirus research (9 papers). Neil Blake collaborates with scholars based in United Kingdom, Germany and China. Neil Blake's co-authors include Alan B. Rickinson, Tracey A. Haigh, Debbie Croom-Carter, Irina Redchenko, Steven P. Lee, Wendy A. Thomas, Alison M. Leese, Pauline Meij, Ann M. Leen and Elisabeth Bloemena and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and Blood.

In The Last Decade

Neil Blake

37 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neil Blake United Kingdom 23 1.1k 1.0k 735 381 376 38 2.0k
Jerome E. Tanner Canada 19 944 0.9× 581 0.6× 530 0.7× 381 1.0× 262 0.7× 34 1.7k
Daphne van Leeuwen Netherlands 18 849 0.8× 797 0.8× 691 0.9× 190 0.5× 233 0.6× 20 1.5k
I S Misko Australia 27 1.5k 1.4× 1.6k 1.6× 934 1.3× 515 1.4× 309 0.8× 49 2.6k
Paula S. Norris United States 20 493 0.5× 1.1k 1.1× 510 0.7× 174 0.5× 528 1.4× 30 2.0k
Misako Yajima Japan 15 566 0.5× 458 0.5× 365 0.5× 223 0.6× 210 0.6× 25 1.1k
Lesley S. Morris United Kingdom 15 577 0.5× 917 0.9× 567 0.8× 144 0.4× 666 1.8× 19 2.3k
Linda Tan United Kingdom 9 648 0.6× 1.2k 1.2× 548 0.7× 180 0.5× 215 0.6× 11 1.7k
Dagmar Pich Germany 21 1.5k 1.4× 563 0.6× 935 1.3× 468 1.2× 679 1.8× 29 2.3k
Seiji Maruo Japan 26 1.2k 1.1× 1.1k 1.1× 471 0.6× 491 1.3× 535 1.4× 34 2.1k
Hiroki Isomura Japan 28 1.1k 1.0× 335 0.3× 1.3k 1.8× 163 0.4× 602 1.6× 52 2.1k

Countries citing papers authored by Neil Blake

Since Specialization
Citations

This map shows the geographic impact of Neil Blake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Blake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Blake more than expected).

Fields of papers citing papers by Neil Blake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Blake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Blake. The network helps show where Neil Blake may publish in the future.

Co-authorship network of co-authors of Neil Blake

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Blake. A scholar is included among the top collaborators of Neil Blake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Blake. Neil Blake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xia, Rong, Jiaming Huang, Kunqi Chen, et al.. (2024). Interpretable deep cross networks unveiled common signatures of dysregulated epitranscriptomes across 12 cancer types. Molecular Therapy — Nucleic Acids. 35(4). 102376–102376. 3 indexed citations
3.
Blake, Neil. (2021). COVID-19 and the economic implications for office occupiers. 10(3). 310–310. 1 indexed citations
4.
Blake, Neil, et al.. (2021). Dynamics of m6A RNA Methylome on the Hallmarks of Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology. 9. 642443–642443. 18 indexed citations
5.
Antoniou, Antony N., János Kriston-Vizi, Takao Iwawaki, et al.. (2018). Salmonella exploits HLA-B27 and host unfolded protein responses to promote intracellular replication. Annals of the Rheumatic Diseases. 78(1). 74–82. 39 indexed citations
6.
Moss, Alan C., Gregory M. Jacobson, Lauren Walker, et al.. (2008). SCG3 Transcript in Peripheral Blood Is a Prognostic Biomarker for REST-Deficient Small Cell Lung Cancer. Clinical Cancer Research. 15(1). 274–283. 47 indexed citations
8.
Lee, Steven P., Jill Brooks, Wendy A. Thomas, et al.. (2004). CD8 T Cell Recognition of Endogenously Expressed Epstein-Barr Virus Nuclear Antigen 1. The Journal of Experimental Medicine. 199(10). 1409–1420. 125 indexed citations
10.
Rickinson, Alan B., et al.. (2003). TAP-independent antigen presentation on MHC class I molecules: lessons from Epstein–Barr virus. Microbes and Infection. 5(4). 291–299. 53 indexed citations
11.
Antoniou, Antony N., et al.. (2002). Interactions formed by individually expressed TAP1 and TAP2 polypeptide subunits. Immunology. 106(2). 182–189. 40 indexed citations
12.
Blake, Neil, et al.. (2000). The Importance of Exogenous Antigen in Priming the Human CD8+ T Cell Response: Lessons from the EBV Nuclear Antigen EBNA1. The Journal of Immunology. 165(12). 7078–7087. 112 indexed citations
13.
Moins‐Teisserenc, Hélène, Stephan D. Gadola, Marina Cella, et al.. (1999). Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules. The Lancet. 354(9190). 1598–1603. 91 indexed citations
14.
Blake, Neil, Irina Redchenko, Wendy Thomas, et al.. (1997). Human CD8 + T Cell Responses to EBV EBNA1: HLA Class I Presentation of the (Gly-Ala)–Containing Protein Requires Exogenous Processing. Immunity. 7(6). 791–802. 222 indexed citations
15.
Moins‐Teisserenc, Hélène, Wilhelm H. Schmitt, Neil Blake, et al.. (1997). A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway. Immunology Letters. 57(1-3). 183–187. 37 indexed citations
16.
Lee, Steven P., Wendy A. Thomas, Neil Blake, & Alan B. Rickinson. (1996). Transporter (TAP)‐independent processing of a multiple membrane‐spanning protein, the Epstein‐Barr virus latent membrane protein 2. European Journal of Immunology. 26(8). 1875–1883. 51 indexed citations
18.
Yousef, G.E., Louise Cunningham, Neil Blake, et al.. (1993). Attenuation of a reactivated cardiovirulent coxsackievirus B3: The 5′‐nontranslated region does not contain major attenuation determinants. Journal of Medical Virology. 41(2). 129–137. 40 indexed citations
19.
Blake, Neil, et al.. (1992). Molluscum contagiosum virus. PubMed. 1. 233–257. 12 indexed citations
20.
Coulson, Judy M., Neil Blake, L. C. Archard, & ALAN D. B. MALCOLM. (1992). Antisense Oligodeoxynucleotides as antiviral agents. Biochemical Society Transactions. 20(4). 321S–321S.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026